At a glance: Plasmapheresis — also called plasma exchange — is a procedure in which the liquid portion of a child's blood is separated from the blood cells, removed, and replaced with donor plasma or a substitute solution before being returned to the body. In PANS and PANDAS, the goal is to physically remove the harmful antibodies believed to be attacking brain tissue and driving neuropsychiatric symptoms. It is generally discussed for children with severe or treatment-resistant presentations who have not responded adequately to earlier interventions.
For most families navigating PANS and PANDAS, plasmapheresis is not a word that comes up early in the treatment conversation. It enters the picture for a smaller subset of children — those whose presentations are severe, whose symptoms have not responded adequately to antibiotics and IVIG, or who are in such acute distress that a more direct intervention is warranted from the start. When it does come up, parents often feel a combination of hope and fear — hope that something more powerful might finally move the needle, and fear of what a procedure this intensive means for their child.
Understanding what plasmapheresis actually involves, how it differs from IVIG, what the evidence says about it, and under what circumstances experienced providers consider it — gives families a clearer framework for thinking about it if it ever becomes part of the conversation for their child.
The distinction between plasmapheresis and IVIG is important and worth understanding clearly, because they are sometimes discussed as if they are interchangeable — two versions of the same thing. They are not. They work through fundamentally different mechanisms and serve different purposes within the treatment framework.
IVIG works by introducing a large volume of normal, healthy antibodies into the bloodstream. The theory is that flooding the immune system with normal antibodies helps modulate the harmful autoimmune response — shifting the immune environment rather than directly removing the problematic elements.
Plasmapheresis takes a more direct approach. Rather than adding something to the bloodstream, it removes something. The plasma — the liquid portion of the blood that carries antibodies, proteins, and other immune signaling molecules — is separated from the blood cells, and the portion containing the harmful antibodies is physically filtered out and replaced. The blood cells are returned to the body along with the replacement fluid.
💡 Think of it this way: if IVIG is like adding clean water to a contaminated pool to dilute the problem, plasmapheresis is like draining the pool and refilling it. One works by shifting the balance. The other works by direct removal. Both aim to reduce the harmful immune activity driving symptoms — they just approach the problem from different directions.
Plasmapheresis is performed in a hospital setting, typically by a team that includes a specialist experienced in the procedure — often an apheresis specialist or a pediatric nephrologist or hematologist with relevant training. It is not an outpatient procedure in the way that IVIG can sometimes be arranged.
The procedure requires IV access — in some cases, a temporary central line or special large-bore IV catheter to allow blood to move through the apheresis machine at the required rate. Blood is drawn out of the body, passed through a machine that separates the plasma from the blood cells, and the separated plasma is replaced with donor plasma, albumin, or another replacement solution before the blood is returned.
A typical course for PANS and PANDAS involves multiple sessions over the course of about a week to ten days, though the specific protocol varies by center and by the child's clinical situation. Each session takes several hours. The child is monitored throughout and remains in the hospital or returns daily for outpatient sessions depending on the facility's approach.
📊 Key procedural considerations for families:
The research on plasmapheresis for PANS and PANDAS is smaller than the evidence base for IVIG, and it is important to present that honestly rather than overstating what is known.
The foundational controlled study — the same NIMH trial from the late 1990s that examined IVIG — also included a plasmapheresis arm. Children in that study who received plasmapheresis showed significant symptom improvement compared to the placebo group, with some evidence suggesting effects comparable to or exceeding those seen with IVIG. Subsequent case series and clinical reports have continued to document meaningful responses in children with severe or treatment-resistant PANDAS.
The honest limitations are these: the studies are small. The populations studied have been specific — generally severe, treatment-resistant presentations. Plasmapheresis has not been studied in the large randomized controlled trials that would be required to establish it firmly in mainstream treatment guidelines. And the providers experienced enough in PANS and PANDAS to administer and interpret it are not evenly distributed across the country.
What the available evidence does consistently show is that for children who meet the clinical criteria experienced providers use to select candidates — severe presentation, inadequate response to earlier treatment, compelling evidence of autoimmune involvement — plasmapheresis represents a meaningful intervention with a real track record in that specific population. That is neither a guarantee nor a dismissal. It is the honest picture.
Plasmapheresis is not the starting point. It is a step that comes after other interventions have been tried and found insufficient — or, in some severe presentations, a step that is considered earlier because the clinical picture is urgent enough to warrant moving quickly to a more direct intervention.
📊 Clinical situations where plasmapheresis is generally discussed in PANS/PANDAS:
What plasmapheresis is generally not used for:
💬 If this framework is clicking for you and you're tired of piecing things together from random posts and forums, consider joining the Spectrum Care Hub Learning Community. You'll get full access to step-by-step biomedical coursework, printable tools, and new lessons added every month. Click here for details
One of the practical realities of plasmapheresis is that it is not available everywhere. Not every children's hospital has a pediatric apheresis program, and not every apheresis program has experience applying the procedure in the context of PANS and PANDAS. Families may need to travel — sometimes significantly — to access a center with the right combination of PANS expertise and apheresis capability.
This is worth knowing before the conversation becomes urgent. If your child's presentation is severe and treatment-resistant, asking your PANS provider early about which centers they work with or refer to for plasmapheresis — and what the logistics of accessing that care would look like — is a practical and appropriate question.
The financial picture is also significant. Plasmapheresis involves hospitalization, specialized equipment, a multi-disciplinary team, and multiple sessions. It is among the more expensive interventions in the PANS and PANDAS treatment landscape. Insurance coverage varies, and the prior authorization process can be complex. As with IVIG, having a direct conversation with your provider about the insurance documentation they can provide and the realistic cost picture before committing to the process is worth doing.
For children who respond to plasmapheresis, improvement can be meaningful — sometimes dramatically so. Parents who have watched their child struggle through severe, treatment-resistant symptoms for months or years sometimes describe the period after successful plasmapheresis as the first time they recognized their child again.
That response, when it happens, is real and worth naming. It is also not universal, and the trajectory of recovery is not always immediate or linear. Some children improve rapidly. Others have a more gradual course. Some require additional treatment following plasmapheresis — continued antibiotics, anti-inflammatory support, behavioral therapy — to consolidate and build on the gains the procedure produced.
What plasmapheresis does is remove a significant portion of the harmful antibodies circulating at the time of the procedure. It does not permanently reprogram the immune system or eliminate the underlying vulnerability to future episodes. Ongoing management — prophylactic antibiotics in some children, attention to infection prevention, and continued behavioral support — typically remains part of the picture after the acute intervention.
Small improvements in the weeks following the procedure — better sleep, less intense OCD rituals, more emotional regulation, more food acceptance — are real progress even when full recovery still feels far away. These are the signals worth tracking and naming.
How do we know if our child needs plasmapheresis rather than IVIG? That determination requires a thorough evaluation by a provider experienced in PANS and PANDAS who can weigh your child's symptom severity, treatment history, and relevant testing results. Generally, IVIG is considered before plasmapheresis — plasmapheresis is most commonly discussed when IVIG has not produced adequate improvement or when the clinical picture is severe enough to warrant moving more quickly. There is no single rule that applies to every child.
Is plasmapheresis safe for children? Plasmapheresis is a procedure with an established safety record in pediatric medicine, used for a range of conditions beyond PANS and PANDAS. As with any medical procedure, it carries risks that require discussion with the treating team — these include reactions to the replacement fluid, effects related to IV access, and changes in blood chemistry that are monitored during treatment. A team experienced in pediatric apheresis manages these risks actively during the procedure. The risk-benefit conversation is one for your child's medical team, based on their specific clinical picture.
What happens if plasmapheresis doesn't work? For children who do not respond adequately to plasmapheresis, the treatment conversation shifts to longer-term immune management strategies, which may include ongoing IVIG at regular intervals, rituximab in some severe refractory cases, and continued optimization of infection prevention and anti-inflammatory support. These conversations happen at specialized PANS centers with significant experience in complex presentations.
Can my child have plasmapheresis at our local children's hospital? It depends on whether your local children's hospital has a pediatric apheresis program and whether the team there has experience with PANS and PANDAS. Many do not. Asking your PANS provider specifically which centers they recommend or refer to — and whether telehealth consultation with a more specialized center is possible to guide local treatment — is a practical starting point.
How do we prepare our child emotionally for this procedure? This is a real and important question. A procedure involving IV access, hours of monitoring, and multiple sessions over days is significant for any child — particularly one who may already be dysregulated and anxious from their PANS or PANDAS symptoms. Child life specialists at hospital apheresis centers are trained to help children understand and cope with medical procedures. Asking specifically about child life support when you are arranging the procedure is worth doing, and preparing your child with honest, age-appropriate information about what to expect generally goes further than avoidance.
💬 If this helped you see your child's behavior and biology in a new light, the next step is to keep building on that clarity. Our Spectrum Care Hub subscription gives you the complete course library, deeper dive modules, and ongoing support, so you don't have to navigate autism and PANS/PANDAS care alone. Click here for details
Last reviewed by Mary Margaret Burch, FNP-BC — March 2026 © 2026 Spectrum Care Hub LLC / SpectrumCareHub.com. This article is for educational purposes only. Nothing here constitutes medical advice or creates a provider-patient relationship. Always work with a qualified, licensed healthcare provider before making any medical decisions for your child.